Literature DB >> 3480917

Serum CA 15.3 levels in patients with non-tumoral diseases, and establishment of a threshold for tumoral activity. Results in 1219 patients.

A Ruibal, J Genollá, M Rosell, J M Gris, R Colomer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3480917     DOI： 10.1177/172460088600100308

Source DB:  PubMed          Journal:  Int J Biol Markers        ISSN： 0393-6155            Impact factor:   3.248


× No keyword cloud information.
  3 in total

1.  Evaluation of serum CA15-3 determination with CEA and TPA in the post-operative follow-up of breast cancer patients.

Authors:  A Nicolini; C Colombini; L Luciani; A Carpi; L Giuliani
Journal:  Br J Cancer       Date:  1991-07       Impact factor: 7.640

2.  Role of 2-[18F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in the post-therapy surveillance of breast cancer.

Authors:  Hong-Tai Chang; Chin Hu; Yu-Li Chiu; Nan-Jing Peng; Ren-Shyan Liu
Journal:  PLoS One       Date:  2014-12-17       Impact factor: 3.240

3.  CA15.3 serum concentrations in older women with infiltrating ductal carcinomas of the breast.

Authors:  Álvaro Ruibal; Pablo Aguiar; María Carmen Del Río; María Elena Padín-Iruegas; José Ignacio Arias; Michel Herranz
Journal:  Int J Mol Sci       Date:  2014-10-31       Impact factor: 5.923
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.